GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Silverman who wrote (2519)	4/19/2000 3:08:00 PM
From: Mad2	Read Replies (1) of 5582

Dave, I myself don't dispute that Zicam shows some benifit, however I don't want to get in a spitting match about how effective, etc..... I would point out that Quigly's zinc tablets also provide some benifit as well, however that alone is no cure for the illness surrounding their stock (QGLY on the NASDAQ), plane old butt ugly for those who have been in it since its heyday. Ultimatly GUMM will be valued as all companies are, according for their ability to generate earnings, factoring up or down for the stregth of the balance sheet. Near term earnings and quarterly results will drive this stock. GUMM might be a potential play (to the upside) come May/June or sometime this summer, depending on how their upcoming financials look as well as the markets desire to buy speculative small caps. mad2

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next